Pharming (PHAR) EBITDA (2020 - 2026)
Pharming (PHAR) posted EBITDA of $2.56 million for Q2 2026, down 71.9% from $9.09 million a year earlier.
Powered by 
Analysis
Pharming (PHAR) EBITDA (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Pharming was $22.55 million, up 129.5% year-over-year; for FY2025, it was $37.06 million.
- Annual EBITDA shows a five-year compound annual growth rate of -15.2% (FY2020 to FY2025).
- In prior years, Pharming's EBITDA was $770,000 in FY2024 (-92.7%), $10.54 million in FY2023 (-74.7%), $41.59 million in FY2022 (+13.0%) and $36.81 million in FY2021 (-56.3%).
- The Q2 2026 figure stands as the lowest quarterly EBITDA since Q2 2024.
- On a year-over-year basis, EBITDA increased in 1 of the last four quarters, with an average decline of 24.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.58 Bn | 1,139.17 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 639.26 Bn | 557.79 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.86 Bn | 474.97 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 374.72 Bn | 329.10 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.72 Bn | 266.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.40 Bn | 242.08 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 242.11 Bn | 197.51 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 193.45 Bn | 167.65 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Pharming | 743.88 Mn | -50.49 Mn | 141.47 Mn | 2.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56 Mn |
| Dec 31, 2025 | 3.21 Mn |
| Jun 30, 2025 | 12.79 Mn |
| Dec 31, 2024 | 13.42 Mn |
| Sep 30, 2024 | 6.84 Mn |
| Jun 30, 2024 | -13.81 Mn |
| Dec 31, 2023 | 8.66 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Dec 31, 2022 | -8.01 Mn |
| Sep 30, 2022 | 9.75 Mn |
| Dec 31, 2021 | 17.36 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Dec 31, 2020 | 21.20 Mn |
| Sep 30, 2020 | 24.30 Mn |
API Access
Pharming EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();